Abstract
Sleep deprivation, a common perioperative period health problem, causes ocular discomfort and affects postsurgical pain. However, the mechanism of sleep deprivation-induced increased pain sensitivity is elusive. This study aims to explore the role of ROS in sleep deprivation (SD)-induced hyperalgesia and the underlying mechanism. A 48-h continuous SD was performed prior to the hind paw incision pain modeling in mice. We measured ROS levels, microglial activation, DNA damage and protein levels of iNOS, NLRP3, p-P65 and P65 in mouse spinal dorsal cord. The involvement of ROS in SD-induced prolongation of postsurgical pain was further confirmed by intrathecal injection of ROS inhibitor, phenyl-N-tert-butylnitrone (PBN). Pretreatment of 48-h SD in mice significantly prolonged postsurgical pain recovery, manifesting as lowered paw withdrawal mechanical threshold and paw withdrawal thermal latency. It caused ROS increase and upregulation of iNOS on both Day 1 and 7 in mouse spinal dorsal cord. In addition, upregulation of NLRP3 and p-P65, microglial activation and DNA damage were observed in mice pretreated with 48-h SD prior to the incision. Notably, intrathecal injection of PBN significantly reversed the harmful effects of SD on postsurgical pain recovery, hyperalgesia, microglial activation and DNA damage via the NF-κB signaling pathway. Collectively, ROS increase is responsible for SD-induced hyperalgesia through activating microglial, triggering DNA damage and enhancing NLRP3 inflammasome activity in the spinal dorsal cord.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
There are up to 300 million surgical procedures annually in the world [1]. About 10–50% of surgical patients suffer continuous postsurgical pain [2], of which, about 2–10% is severe pain that lasts for at least one year [3]. Postoperative pain that persists for 3 months or longer is known as chronic postsurgical pain (CPSP), which is a common surgical outcome leading to long-term use of analgesics and lower health-related quality of life [4]. Risk factors of CPSP are diverse, including acute postsurgical pain, genetic susceptibility, preceding pain, age, sex, and psychosocial factors (e.g., perioperative sleep disorder, fear, and anxiety) [5]. Recent research has highlighted the negative influence of perioperative sleep deprivation (SD) on CPSP [6]. SD significantly causes hyperalgesia, and it further enhances pain facilitation [7]. Therefore, SD is considered as an etiological factor of chronic pain.
Short-term SD results in the increased levels of systemic reactive oxygen species (ROS), followed by serious physiological changes [8, 9]. During bedtime, sleep is responsible for fighting against oxidative stress, thus maintaining the normal function of the central nervous system (CNS). SD, however, breaks the balance of prooxidants and antioxidants in the CNS, that is, excessive ROS overwhelm the antioxidant system [10]. The imbalance of ROS production and antioxidants further causes malfunction or structure modification of major cellular DNAs [11, 12]. During the progression of neurodegenerative diseases, ROS generated by activated microglia are the murderer for neuroinflammation [13]. Jun et al. [14] reported that increased ROS upregulate NLRP3 inflammasome via the NF-κB signaling pathway. Activation of NLRP3 inflammasome contributes to pain development [15]. The exact mechanism underlying the role of ROS in perioperative SD-induced neuroinflammation, and the following chronic postsurgical pain, still remains unclear.
In the current study, a 48-h continuous SD was performed prior to the hind paw incision pain modeling in mice. We examined whether ROS-induced activation of microglia and NLRP3 inflammasome in spinal dorsal cord attributed to prolonged pain recovery time, and whether SD-induced mechanical allodynia and activation of NLRP3 inflammasome could be attenuated by ROS inhibitor phenyl-N-tert-butylnitrone (PBN). Finally, we explored the molecular mechanisms of perioperative SD in exacerbating postsurgical pain.
Materials and Methods
Animals
C57BL/6J mice with 8 weeks old (Beijing Vital River Laboratory Animal Technology, Beijing, China) were housed in the animal facility at a controlled temperature (21 ± 1 °C) with a standard 12-h light/dark cycle. They had free accesses to laboratory water and food pellets. In vivo experiments were approved by the Laboratory Animal of the Ethics Committee of Nanjing Drum Tower Hospital. They were randomly assigned into control group (con group), incisional pain model group (I group), SD procedure group (SD group) and SD procedure + incisional pain model group (SD + I group). In addition, mice intervened by SD procedures and incisional pain modeling were intrathecally injected with 100 µg/5 µl PBN (SD + I + PBN group) or isodose vehicle (SD + I + Veh group) during SD period and the day before making the incision.
SD Procedures
The continuous 48-h SD was performed using a SD instrument (XR-XS108, Xinruan, Shanghai) with minor modifications of previously reported procedures [16]. Briefly, mice were placed in a cage, where a sweeper bar was moved along the bottom. An electrical motor system was used to control the speed, torque, and interval of the intermittent/continuous functioning mode of the sweeper, thus eliminating human errors. Mice needed to step over the sweeper and then resumed their unrestrained behaviors during the sweeper motion, and those maintained in the cage for continuous 48 h before the hind paw incision surgery were given food and water ad libitum.
Incisional Pain Model in Mice
The plantar incisional surgery was performed as previously reported [17]. Briefly, mice were anesthetized with sevoflurane delivered via a small nose cone. The plantar aspect of the right hind paw was sterilized with a 10% povidone–iodine solution. A 0.5-cm longitudinal incision was made through the skin and fascia of the planter aspect of hind paw. The incision started from the edge of the heel and extended toward the toes. The plantar muscle was exposed, elevated and incised longitudinally. The skin was sutured with 5-0 nylon thread after hemostasis with gentle pressure. Mice were allowed to recover in their facilities postoperatively.
Behavioral Analysis
Mechanical allodynia and paw withdrawal latency to a noxious heat stimuli were tested prior to SD (baseline), Day -2 and -1 during SD procedures, and Day 1, 3, 5, 7, 9 and 14 after incisional surgery.
Paw Withdrawal Mechanical Threshold (PWMT)
Mechanical allodynia was performed by a series of von Frey filaments (Stoelting, USA). Briefly, mice were placed into individual transparent plexiglass compartments (length × width × height: 10 × 10 × 15 cm) onto a metal mesh floor (graticule: 0.5 × 0.5 cm). After acclimatized for at least 30 min, Von Frey filaments (0.16, 0.4, 0.6, 1.0, 1.4, and 2.0 g) were vertically poked into the plantar surface of the right hind paw and held in place for 6–8 s, which was tested for five times. The lowest stimulus strength that caused brisk withdrawal of the paw or paw flinching that produced three or more positive responses in total five times was regarded as PWMT.
Paw Withdrawal Thermal Latency (PWTL)
PWTL to a noxious heat stimulus was measured by the Model 336 Analgesic Meter (IITC Inc./Life Science Instruments, Woodland Hills, USA). Briefly, mice were placed in an individual plexiglass compartments (length × width × height: 10 × 10 × 15 cm) on a glass plate. The middle of the plantar surface of the right hind paw receipted a radiant heat produced by a light beam through the glass plate, which was turned off after foot lifting. The duration from the start of the light beam and foot lifting was recorded as PWTL. Each test was repeated five times with a 5-min interval. To avoid tissue damage to the hind paw, a cut-off time of 25 s was necessary.
Drug Administration
N-tert-Butyl-α-phenylnitrone (PBN, Sigma-Aldrich, St. Louis, MO, USA) was dissolved in 0.9% saline (20 μg/μl). Mice were treated with 100 μg/5 μl PBN or saline by intrathecal injection (i.t.) into the mouse lumbar subarachnoid space at the L5–L6 intervertebrae for continuous 3 days, according to the modification of a method described previously [18]. The plantar incisional surgery was performed half an hour after the third administration of PBN.
Western Blotting
Mice were sacrificed under overdose sevoflurane. Tissue proteins from the entire lumbosacral enlargement of spinal cord was extracted and homogenized in ice-cold RIPA Lysis Buffer containing protease inhibitor cocktail and lysates. Tissue samples were then centrifuged at 4 °C, 12,000 rpm for 15 min, and the supernatants were collected for further examination. The protein concentration was determined using an enhanced BCA Protein Assay Kit (P0010, Beyotime, China). A total of 20 μg protein of each sample was separated by an appropriate concentration of SDS-PAGE (PG-112, Epizyme Biotech, China) and then transferred onto polyvinylidene fluoride (PVDF) membranes (IPVH00010, Millipore, USA). The membranes were first blocked with 5% non-fat milk for 1 h at room temperature (RT) and then incubated with indicated primary antibodies against NLRP3 (ab263899, 1:1000, RRID:AB_9890, Abcam, USA), iNOS (ab178945, 1:1000, RRID:AB_2861417, Abcam, USA), P65 (#8242, 1:1000, RRID:AB_10859369, CST, USA), p-P65 (#3033, 1:1000, RRID:AB_331284, CST, USA), and β-actin (bs-0061R, 1:5000, RRID:AB_10855480, Bioss, China) overnight at 4 °C. The membranes were incubated with goat anti-rabbit IgG secondary antibody (A0208, 1:1000, RRID:AB_2892644, Beyotime, China) for 1 h at RT after washing with TBST. Finally, Protein bands were visualized with ECL Prime Detection Reagent (E412-02, Vazyme, China). Images were captured using a cooled CCD system (4600SF, Tanon, China). Quantitative densitometry analysis was performed using Image J (NIH, Bethesda, MD).
Immunofluorescence Staining
Under deep anesthesia with sevoflurane, the entire lumbosacral enlargement was quickly removed, fixed with 4% paraformaldehyde, and dehydrated in 30% sucrose. The L3-L5 spinal cords were transversely cut into 25-μm-thick sections and mounted on glass slides. Sections were blocked and then incubated with primary antibodies against Iba-1 (#019-19741, 1:700, RRID:AB_839504, Wako, Japan) and 8-OHdG (ab62623, 1:500, RRID:AB_940049, Abcam, USA) overnight at 4 °C. After washing with phosphate-buffered saline (PBS), sections were incubated with Alexa 488-conjugated goat anti-rabbit antibody (A32731, 1:1000, RRID:AB_2633280, Thermo Fisher, USA) and Alexa 594-conjugated goat anti-mouse antibody (A32742, 1:1000, RRID:AB_2762825, Thermo Fisher, USA) in the dark. 3 of spinal cord sections per animal were employed for further statistical analysis. The fluorescence intensity of Iba1 and 8-OHdG were measured by Image J (NIH, Bethesda, MD).
Measurement of ROS Levels
The lumbosacral enlargement of spinal cord samples (200 mg) was washed with PBS, and homogenized in ice-cooled Tris–HCL buffer (40 mM, pH 7.4). A total of 100 μl of tissue homogenates were incubated with the diluted 10 μM DCFH-DA (S0033S, Beyotime, China) in Tris–HCL buffer (40 mM, pH 7.4) at 37 °C for 30 min. The fluorescence intensity was assessed by a multifunctional microplate reader (λexcitation = 488 nm and λemission = 525 nm) (Spark, Tecan, Switzerland).
Statistical Analysis
All data were expressed as mean ± SD and evaluated by SPSS software 22.0. Changes of behavioral assessments were analyzed using two-way repeated measures of variance. Differences between two or more groups were compared by the unpaired two-tailed Student’s t test or one-way ANOVA, respectively, followed by the post hoc test (Bonferroni test). P value < 0.05 was accepted as significant.
Results
Pretreatment of Short-Term SD in Mice Prolongs Postsurgical Pain Recovery
In the present study, a continuous 48-h SD was performed prior to the unilateral hind paw plantar incision, aiming to explore the influence of pretreatment of short-term SD on postsurgical pain recovery. Baseline measurements were comparable in con group, I group, SD group and SD + I group. Compared with mice in con group, the incision resulted in persistent mechanical, thermal, and heat pain hypersensitivities on the ipsilateral side of mice in I group. Pain hypersensitivity in I group peaked on Day 1, then gradually recovered, and completely disappeared on Day 7 [con group vs. I group: PWMT: F(3,21) = 38.681, p < 0.001 for group factor, F(8,56) = 48.139, p < 0.001 for time factor, F(24,168) = 7.795, p < 0.001 for interaction; p < 0.001 on Day 1 and 3, p < 0.01 on Day 5; Day 1: F(3,21) = 73.929, p < 0.001 for group factor; Day 3: F(3,21) = 25.216, p < 0.001 for group factor; Day 5: F(3,21) = 21.798, p < 0.001 for group factor; PWTL: F(3,21) = 34.656, p < 0.001 for group factor, F(8,56) = 26.631, p < 0.001 for time factor, F(24,168) = 7.87, p < 0.001 for interaction; p < 0.001 on Day 1 and 3; Day 1: F(3,21) = 85.812, p < 0.001 for group factor; Day 3: F(3,21) = 43.43, p < 0.001 for group factor]. As expected, the continuous 48-h SD exposure significantly reduced PWMT during SD period, and lasted for 5 days following SD exposure [con group vs. SD group: F(3,21) = 34.656, p < 0.001 for group factor, F(8,56) = 35.742, p < 0.001 for time factor, F(24,168) = 4.570, p < 0.001 for interaction; p < 0.05 on Day -2, p < 0.001 on Day -1, 1, and 3, p < 0.01 on Day 5; Day -2: F(3,21) = 1.087, p = 0.361 for group factor; Day -1: F(3,21) = 4.211, p < 0.01 for group factor; Day 1: F(3,21) = 85.812, p < 0.001 for group factor; Day 3: F(3,21) = 43.43, p < 0.001 for group factor; Day 5: F(3,21) = 23.583, p < 0.001 for group factor). Compared with group I, the continuous 48-h SD aggravated and prolonged the postoperative pain of mice in group SD + I (I group vs. SD + I group: PWMT: p < 0.05 on Day -2, p < 0.001 on Day -1, p < 0.01 on Day 5, p < 0.05 on Day 7 and Day 9; Day -2: F(3,21) = 4.548, p = 0.014 for group factor; Day -1: F(3,21) = 21.358, p < 0.001 for group factor; Day 5: F(3,21) = 21.798, p < 0.001 for group factor; Day 7: F(3,21) = 7.857, p < 0.01 for group factor; Day 9: F(3,21) = 6.429, p < 0.05 for group factor) (Fig. 1A, B). Collectively, the above data suggested that pretreatment of short-term SD prolonged postsurgical pain recovery in mice with a unilateral hind paw plantar incision.
Pretreatment of SD Enhances ROS Levels in the Spinal Cord
ROS levels in mouse spinal cord were measured on Day 1 and 7. Compared with those of con group, ROS levels on Day 1 in the remaining groups all significantly increased [con group vs. I group, p < 0.01; con group vs. SD group, p < 0.01; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.01; F(3,12) = 21.228, p < 0.001 for group factor] (Fig. 2A). Consistently, ROS levels in SD + I group on Day 7 were still significantly higher than those of con group and I group [con group vs. group SD + I, p < 0.01; I group vs. SD + I group, p < 0.01; F(3,12) = 20.568, p < 0.001 for group factor] (Fig. 2B). It is suggested that pretreatment of SD increased ROS levels in mouse spinal cord, which, importantly, persistently remained high after the unilateral hind paw plantar incision. Here, we detected the protein level of iNOS in the spinal cord by Western blotting. It was significantly upregulated in I, SD and SD + I group on Day 1 (con group vs. I group, p < 0.001; con group vs. SD group, p < 0.001; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.05; F(3,12) = 51.139, p < 0.001 for group factor). Notably, the high protein level of iNOS lasted on Day 7 in SD + I group (con group vs. SD + I group, p < 0.01; I group vs. SD + I group, p < 0.01; F(3,12) = 11.298, p = 0.001 for group factor), which was consistent with the changes of ROS levels (Fig. 2C, D).
SD-Induced Accumulation of ROS Triggers the Activation of Microglia and DNA Damage in Mouse Spinal Dorsal Cord
ROS are capable of triggering inflammatory response in the CNS. Activated microglia would produce harmful oxidizing agents, which further activate microglia in a vicious circle. On Day 7, positive expression of Iba1 in mouse spinal dorsal cord of SD + I group was significantly higher than that of con group (con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.001; F(2,11) = 25.104, p < 0.001 for group factor;), suggesting the increased activation of microglia in SD + I group on Day 7(Fig. 3A). DNA single-strand break may result from various sources, including environmental factors like ROS. As shown in Fig. 3A, the expression of 8-OHdG (DNA single-strand break marker) in mouse spinal dorsal cord of SD + I group was significantly higher than that of con group on Day 7 (con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.001; F(2,11) = 25.576, p < 0.001 for group factor;) While compared with Con group, the expression of Iba1 and 8-OHdG have no significance in I group and SD group, which was consistent with the changes in pain behavior. (Fig. 3A, B).
SD-Induced Activation NF-κB/NLRP3 in Mouse Spinal Dorsal Cord Contributes to Prolong the Postsurgical Pain
Yang et al. [19] reported that the NF-κB/NLRP3 signaling pathway mediates pain-induced oxidative stress through the involvement of neuroinflammation. We measured protein levels of P65, p-P65 and NLRP3 in mouse spinal dorsal cord on Day 1 and 7 (Fig. 4A). Interestingly, NLRP3 and p-P65 were significantly upregulated in I group, SD group and SD + I group on Day 1 than those of con group (p-P65: con group vs. I group, p < 0.001; con group vs. SD group, p < 0.001; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.01; F(3,12) = 82.249, p < 0.001 for group factor; NLRP3: con group vs. I group, p < 0.001; con group vs. SD group, p < 0.01; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.001; F(3,12) = 151.63, p < 0.001 for group factor). Moreover, their protein levels in SD + I group was still significantly higher than those of con group and I group on Day 7, while no significant differences were detected between the latter two groups (p-P65: con group vs. SD group, p < 0.01; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.001; F(3,12) = 51.29, p < 0.001 for group factor; NLRP3: con group vs. SD group, p < 0.01; con group vs. SD + I group, p < 0.001; I group vs. SD + I group, p < 0.001; F(3,12) = 63.9, p < 0.001 for group factor) (Fig. 4B–D). Our findings thus indicated that pretreatment of SD remarkably prolonged the upregulation of p-P65 and NLRP3 after the unilateral hind paw plantar incision, which further caused SD-induced hyperalgesia associated with potentiated activation of microglia and elevated levels of ROS.
Pretreatment of PBN Alleviates SD-Induced Prolongation of Postsurgical Pain
To confirm the involvement of ROS in SD-induced prolongation of postsurgical pain, the ROS inhibitor PBN (100 µg/5 µl) was injected into mouse intrathecal space during SD period and the day before making the incision. Pretreatment of PBN significantly enhanced PWMT on Day 1, 3, 5, and 7 (SD + I + Veh group vs. SD + I + PBN group, p < 0.001, p < 0.01, p < 0.01, and p < 0.05, respectively) (Fig. 5A). Compared with SD + I + Veh group, PWLT in SD + I + PBN group was slightly elevated during SD period, which strongly increased on postsurgical Day 1, 3, and 5 (SD + I + Veh group vs. SD + I + PBN group, p < 0.01, p < 0.01, p < 0.001, p < 0.001, and p < 0.01, respectively) (Fig. 5B).
Pretreatment of PBN Reduces ROS Levels in Mouse Spinal Dorsal Cord, and Suppresses Microglia Activation and NLRP3 Inflammasome Activity
To further investigate the role of PBN in alleviating SD-induced prolongation of postsurgical pain, we measured protein level of iNOS and ROS levels in mouse spinal dorsal cord. Compared with those of controls, intrathecal injection of PBN significantly downregulated iNOS and ROS levels on Day 7 (SD + I + Veh group vs. SD + I + PBN group, p < 0.001 and p < 0.01, respectively) (Fig. 6A–C). Moreover, microglial activation and DNA damage were significantly alleviated in mice of SD + I + PBN group than those of SD + I + Veh group on Day 7 (SD + I + Veh group vs. SD + I + PBN group, p < 0.05 and p < 0.05, respectively) (Fig. 6D, E). As expected, pretreatment of PBN effectively downregulated NLRP3 and p-P65 in mouse spinal dorsal cord (SD + I + Veh group vs. SD + I + PBN group, p < 0.001 and p < 0.001, respectively) (Fig. 6F–I). Overall, pretreatment of PBN remarkably alleviated SD-induced hyperalgesia by suppressing microglia activation and NLRP3 inflammasome activity in the spinal dorsal cord.
Discussion
In the present study, we carried out a 48-h continuous SD before the hind paw incision surgery model to mimic preoperative sleep disorders in postoperative patients. Our findings demonstrated that SD prolonged postsurgical pain via inducing microglia activation, increasing ROS levels and upregulating p-P65 and NLRP3 in the spinal dorsal cord. Pretreatment of a non-specific ROS scavenger, PBN, by intrathecal administration, effectively alleviated SD-associated pathological development through enhancing PWMT and PWTL, inhibiting microglia activation and suppressing ROS levels via the NF-κB/NLRP3 signaling pathway.
CPSP is a negative outcome of over 3-month pain after surgical procedures [20]. The incidence of CPSP remains high (3–56%), which remains often undermanaged [5]. Most surgical patients have normal pain perception before surgery, but sleep disorders in perioperative period, especially those with critical surgery [21, 22]. Emerging evidence has highlighted the critical role of the perioperative sleep disturbances and sleep disorders in the development of CPSP [23]. Luo et al. [24] revealed that the preoperative Pittsburgh sleep quality index (PSQI) scores are significantly correlated with pain scores at 3 months after total knee and hip arthroplasty, as well as the consumption of analgesics after joint replacement. The lower sleep efficiency the night before surgery of breast cancer patients is associated with a higher postoperative self-reported pain [25]. Poor sleep quality is also linked with the incidence of severe postoperative pain and increased intake of analgesics after delivery [26]. Our data showed that PWMT and PWLT significantly decreased in mice intervened by 48-h continuous SD, which persisted at least for 3 days. A previous study reported that rapid eye movement sleep disturbance (REMSD) 6 h daily for consecutive 3 days does not influence the basal pain sensitivity, including responses to heat, cold and mechanical stimuli [27]. However, REMSD for consecutive 2–4 days in rats markedly reduces PWLT to the heat stimuli [28]. Our findings showed that SD significantly prolonged the recovery of incision-induced decreases in PWMT and PWLT. The underlying mechanism, however, remained unclear.
Previous studies indicate that SD induces oxidative stress in many tissues as well as subsequent decrease in antioxidant capacity [8], and increased ROS in the spinal cord followed by neuroinflammation [29]. Here, we found increased activation of microglia in spinal cord of SD mice, which indicated that inflammatory reaction occurred after SD exposure. Also, SD is capable of affecting DNA integrity by prolonging oxidative stress [30,31,32]. It causes single-strand breaks by attacking deoxyribose through excessively produced ROS. The following response of cells to repair single-strand breaks further results in DNA double-strand breaks and delays DNA repair [32]. SD-induced oxidative stress directly stimulates DNA damage during the pain [33]. Consistently, our results showed increased levels of ROS and 8-hydroxyguanosine (8-OHdG; a modified base formed when DNA is attacked by hydroxyl radicals) in mouse spinal dorsal cord of SD group and SD + I group on Day 1 and 7. Previous studies revealed that excessive ROS generation is associated with endoplasmic reticulum (ER) stress, which induces inflammatory response by activating the nuclear factor-kappa B (NF-κB) signaling pathway [34]. Oxidative stress is involved in the activation of NLRP3 inflammatory corpuscles, which is an important component of innate immunity involved in the process of inflammatory diseases of the CNS [35,36,37]. Latest studies have shown that NLRP3 is up-regulated in both neuropathic and inflammatory pain models, the activation of which, is also involved in the occurrence and maintenance of postoperative pain [38]. Activation of the NLRP3 inflammasome has been linked to NF-kB activation and inflammatory cytokine secretion [39]. The NF-κB/NLRP3 signaling pathway is responsible for mediating hypobaric hypoxia-induced brain injury and traumatic brain injury-induced neuroinflammation [40, 41]. In our study, preoperative SD remarkably activated NLRP3 after making the incision, suggesting the potential role of the NF-κB/NLRP3 signaling pathway in CPSP.
Microglia are of significance in the generation and maintenance of hyperalgesia [42]. Spinal microglia participate in the occurrence and maintenance of chronic pain by regulating the immune response in the spinal cord [43]. Significantly activated substantia nigra microglia are detected in patients with sleep disorders [44]. Our study consistently detected microglia activation in the spinal dorsal cord of SD-induced mice, suggesting that microglial activation was involved in the prolongation of postsurgical pain.
To sum up, the increase in ROS after the short-term SD resulted in DNA damage, followed by microglia sensitization at the spinal cord level. Surgical stress further aggravated DNA damage and DNA escape to the cytoplasm, where NLRP3 was activated and induced CPSP by mediating the inflammatory response. Intrathecal injection of PBN during SD effectively alleviated the incisional pain after SD by reducing ROS levels and DNA damage. Therefore, eliminating ROS is expected to be a promising therapeutic strategy to SD-induced CPSP.
Data availability
The data that support the findings of the current study are available from the corresponding author Zhengliang Ma on reasonable request.
References
Meersch M, Weiss R, Kullmar M, Bergmann L, Thompson A, Griep L, Kusmierz D, Buchholz A, Wolf A, Nowak H, Rahmel T, Adamzik M, Haaker JG, Goettker C, Gruendel M, Hemping-Bovenkerk A, Goebel U, Braumann J, Wisudanto I, Wenk M, Flores-Bergmann D, Bohmer A, Cleophas S, Hohn A, Houben A, Ellerkmann RK, Larmann J, Sander J, Weigand MA, Eick N, Ziemann S, Bormann E, Gerss J, Sessler DI, Wempe C, Massoth C, Zarbock A (2022) Effect of intraoperative handovers of anesthesia care on mortality, readmission, or postoperative complications among adults: The HandiCAP Randomized Clinical Trial. JAMA 327:2403
Meissner W, Zaslansky R (2019) A survey of postoperative pain treatments and unmet needs. Best Pract Res Clin Anaesthesiol 33:269–286
Chapman CR, Vierck CJ (2017) The transition of acute postoperative pain to chronic pain: an integrative overview of research on mechanisms. J Pain 18:359 e351-359 e338
Schug SA, Lavand’homme P, Barke A, Korwisi B, Rief W, Treede RD, Pain ITftCoC (2019) The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. Pain 160:45–52
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625
Lin D, Huang X, Sun Y, Wei C, Wu A (2021) Perioperative sleep disorder: a review. Front Med (Lausanne) 8:640416
Generaal E, Vogelzangs N, Penninx BW, Dekker J (2017) Insomnia, sleep duration, depressive symptoms, and the onset of chronic multisite musculoskeletal pain. Sleep 40
Li S, Tang L, Zhou J, Anchouche S, Li D, Yang Y, Liu Z, Wu J, Hu J, Zhou Y, Yin J, Liu Z, Li W (2022) Sleep deprivation induces corneal epithelial progenitor cell over-expansion through disruption of redox homeostasis in the tear film. Stem Cell Rep 17:1105–1119
Singh R, Kiloung J, Singh S, Sharma D (2008) Effect of paradoxical sleep deprivation on oxidative stress parameters in brain regions of adult and old rats. Biogerontology 9:153–162
Villafuerte G, Miguel-Puga A, Rodriguez EM, Machado S, Manjarrez E, Arias-Carrion O (2015) Sleep deprivation and oxidative stress in animal models: a systematic review. Oxid Med Cell Longev 2015:234952
Sadasivam N, Kim YJ, Radhakrishnan K, Kim DK (2022) Oxidative stress, genomic integrity, and liver diseases. Molecules 27:3159
Wang H, Kodavati M, Britz GW, Hegde ML (2021) DNA damage and repair deficiency in ALS/FTD-associated neurodegeneration: from molecular mechanisms to therapeutic implication. Front Mol Neurosci 14:784361
Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladacenco O, Roza E, Costachescu B, Grumezescu AM, Teleanu RI (2022) An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Int J Mol Sci 23:5938
Jun JH, Shim JK, Oh JE, Shin EJ, Shin E, Kwak YL (2019) Protective effect of ethyl pyruvate against myocardial ischemia reperfusion injury through regulations of ROS-related NLRP3 inflammasome activation. Oxid Med Cell Longev 2019:4264580
Jia M, Wu C, Gao F, Xiang H, Sun N, Peng P, Li J, Yuan X, Li H, Meng X, Tian B, Shi J, Li M (2017) Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain. Mol Pain 13:1744806917719804
Xu M, Liu X, Wang Q, Zhu Y, Jia C (2022) Phosphoproteomic analysis reveals the effects of sleep deprivation on the hippocampus in mice. Mol Omics 18:677–685
Ishida H, Zhang Y, Gomez R, Shannonhouse J, Son H, Banik R, Kim YS (2021) In vivo calcium imaging visualizes incision-induced primary afferent sensitization and its amelioration by capsaicin pretreatment. J Neurosci 41:8494–8507
Wang C, Xu K, Wang Y, Mao Y, Huang Y, Liang Y, Liu Y, Hao J, Gu X, Ma Z, Sun Y (2020) Spinal cannabinoid receptor 2 activation reduces hypersensitivity associated with bone cancer pain and improves the integrity of the blood-spinal cord barrier. Reg Anesth Pain Med 45:783–791
Yang SR, Hua KF, Chu LJ, Hwu YK, Yang SM, Wu CY, Lin TJ, Weng JC, Zhao H, Hsu WH, Liu FC, Liaw WJ, Ma D, Ka SM, Chen A (2020) Xenon blunts NF-kappaB/NLRP3 inflammasome activation and improves acute onset of accelerated and severe lupus nephritis in mice. Kidney Int 98:378–390
Werner MU, Kongsgaard UE (2014) I. Defining persistent post-surgical pain: is an update required? Br J Anaesth 113:1–4
Chouchou F, Khoury S, Chauny JM, Denis R, Lavigne GJ (2014) Postoperative sleep disruptions: a potential catalyst of acute pain? Sleep Med Rev 18:273–282
Hardin KA (2009) Sleep in the ICU: potential mechanisms and clinical implications. Chest 136:284–294
Varallo G, Giusti EM, Manna C, Castelnuovo G, Pizza F, Franceschini C, Plazzi G (2022) Sleep disturbances and sleep disorders as risk factors for chronic postsurgical pain: a systematic review and meta-analysis. Sleep Med Rev 63:101630
Luo ZY, Li LL, Wang D, Wang HY, Pei FX, Zhou ZK (2019) Preoperative sleep quality affects postoperative pain and function after total joint arthroplasty: a prospective cohort study. J Orthop Surg Res 14:378
Wang JP, Lu SF, Guo LN, Ren CG, Zhang ZW (2019) Poor preoperative sleep quality is a risk factor for severe postoperative pain after breast cancer surgery: a prospective cohort study. Medicine (Baltimore) 98:e17708
Orbach-Zinger S, Fireman S, Ben-Haroush A, Karoush T, Klein Z, Mazarib N, Artyukh A, Chen R, Ioscovich A, Eidelman LA, Landau R (2017) Preoperative sleep quality predicts postoperative pain after planned caesarean delivery. Eur J Pain 21:787–794
Wang PK, Cao J, Wang H, Liang L, Zhang J, Lutz BM, Shieh KR, Bekker A, Tao YX (2015) Short-term sleep disturbance-induced stress does not affect basal pain perception, but does delay postsurgical pain recovery. J Pain 16:1186–1199
Hakki Onen S, Alloui A, Jourdan D, Eschalier A, Dubray C (2001) Effects of rapid eye movement (REM) sleep deprivation on pain sensitivity in the rat. Brain Res 900:261–267
Tanabe M, Nagatani Y, Saitoh K, Takasu K, Ono H (2009) Pharmacological assessments of nitric oxide synthase isoforms and downstream diversity of NO signaling in the maintenance of thermal and mechanical hypersensitivity after peripheral nerve injury in mice. Neuropharmacology 56:702–708
Agrawal S, Singh V, Singh C, Singh A (2022) A review on pathophysiological aspects of Sleep Deprivation. CNS Neurol Disord Drug Targets. https://doi.org/10.2174/1871527321666220512092718
Moreno-Villanueva M, von Scheven G, Feiveson A, Burkle A, Wu H, Goel N (2018) The degree of radiation-induced DNA strand breaks is altered by acute sleep deprivation and psychological stress and is associated with cognitive performance in humans. Sleep. https://doi.org/10.1093/sleep/zsy067
Bellesi M, Bushey D, Chini M, Tononi G, Cirelli C (2016) Contribution of sleep to the repair of neuronal DNA double-strand breaks: evidence from flies and mice. Sci Rep 6:36804
Lee I, Kim HK, Kim JH, Chung K, Chung JM (2007) The role of reactive oxygen species in capsaicin-induced mechanical hyperalgesia and in the activities of dorsal horn neurons. Pain 133:9–17
From the American Association of Neurological Surgeons ASoNC, Interventional Radiology Society of Europe CIRACoNSESoMINTESoNESOSfCA, Interventions SoIRSoNS, World Stroke O, Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA, Shazam Hussain M, Jansen O, Jayaraman MV, Khalessi AA, Kluck BW, Lavine S, Meyers PM, Ramee S, Rufenacht DA, Schirmer CM, Vorwerk D (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612–632
Munoz-Jurado A, Escribano BM, Caballero-Villarraso J, Galvan A, Aguera E, Santamaria A, Tunez I (2022) Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action. Inflammopharmacology. https://doi.org/10.1007/s10787-022-01011-0
Tastan B, Arioz BI, Genc S (2022) Targeting NLRP3 inflammasome With Nrf2 inducers in central nervous system disorders. Front Immunol 13:865772
Sho T, Xu J (2019) Role and mechanism of ROS scavengers in alleviating NLRP3-mediated inflammation. Biotechnol Appl Biochem 66:4–13
Frank MG, Fonken LK, Watkins LR, Maier SF (2020) Acute stress induces chronic neuroinflammatory, microglial and behavioral priming: a role for potentiated NLRP3 inflammasome activation. Brain Behav Immun 89:32–42
Yarmohammadi F, Hayes AW, Karimi G (2021) Possible protective effect of resolvin D1 on inflammation in atrial fibrillation: involvement of ER stress mediated the NLRP3 inflammasome pathway. Naunyn Schmiedebergs Arch Pharmacol 394:1613–1619
Ding W, Cai C, Zhu X, Wang J, Jiang Q (2022) Parthenolide ameliorates neurological deficits and neuroinflammation in mice with traumatic brain injury by suppressing STAT3/NF-kappaB and inflammasome activation. Int Immunopharmacol 108:108913
Xie N, Fan F, Jiang S, Hou Y, Zhang Y, Cairang N, Wang X, Meng X (2022) Rhodiola crenulate alleviates hypobaric hypoxia-induced brain injury via adjusting NF-kappaB/NLRP3-mediated inflammation. Phytomedicine 103:154240
Donnelly CR, Andriessen AS, Chen G, Wang K, Jiang C, Maixner W, Ji RR (2020) Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics 17:846–860
Haight ES, Forman TE, Cordonnier SA, James ML, Tawfik VL (2019) Microglial modulation as a target for chronic pain: from the bench to the bedside and back. Anesth Analg 128:737–746
Stokholm MG, Iranzo A, Ostergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Moller A, Gaig C, Brooks DJ, Tolosa E, Pavese N (2017) Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol 16:789–796
Acknowledgements
This work was supported by the National Natural Science Foundation of China (Grant Numbers 81870875, 81971044); Fundamental Research Funds for the Central Universities (Grant Number 3332021082); China Postdoctoral Science Foundation (Grant Number 2021M701678).
Funding
This work was supported by the National Natural Science Foundation of China (Grant Numbers 81870875, 81971044); Fundamental Research Funds for the Central Universities (Grant Number 3332021082); China Postdoctoral Science Foundation (Grant Number 2021M701678).
Author information
Authors and Affiliations
Contributions
ZM and WZ designed and supervised the study; YH and JH built the model and collected the data; XL, LX, YE, and YL analyzed the data; XG embroidered the manuscript; ZM, WZ, YH and JH wrote the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Huang, Y., Hao, J., Yang, X. et al. Pretreatment of the ROS Inhibitor Phenyl-N-tert-butylnitrone Alleviates Sleep Deprivation-Induced Hyperalgesia by Suppressing Microglia Activation and NLRP3 Inflammasome Activity in the Spinal Dorsal Cord. Neurochem Res 48, 305–314 (2023). https://doi.org/10.1007/s11064-022-03751-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-022-03751-5